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Effects of adenine nucleotides and nucleosides on 
cardiac and smooth muscle which could not readily 
be explained in terms of their intracellular actions 
were first reported more than 50 years ago. In fact 
description of the agonist role of the adenine nucleo- 
tides preceded recognition of their crucial importance 
in the energy transfer cycle within cells. However 
until recently there has not been wide recognition or 
acceptance of the existence of purinergic receptors 
despite xtensive documentation of the properties 
typically associated with such a system. For example, 
granular storage and release of adenine nucleotides 
(ATP or ADP) is well established for a number of 
cells, e.g., platelets, adrenal medullary cells, mast 
cells. Enzymes which degrade ATP and/or ADP have 
also been widely described and for many tissues there 
is now good evidence that a portion of the ATPase 
(or ADPase) is located in the plasma membrane with 
its active site accessible to the extracellular environ- 
ment, i.e., ecto-ATPases and ADPases are widely 
distributed. In the case of adenosine there is wide- 
spread evidence for cellular uptake mechanisms and 
the existence within the cell of a cytosolic degrada- 
tive enzyme (adenosine deaminase). Thus mechanisms 
are known to exist for the release and the inactivation 
of adenine nucleotides and nucleosides as is the case 
for other transmitter systems, These aspects get 
surprisingly little attention in this book which takes 
a much more pharmacological approach to the status 
of purinergic receptors. 
In the introductory article Burnstock, the main 
proponent of the purinergic nerve hypothesis, and 
Brown provide a very thorough survey of systems 
which have been shown to respond to purine nucleo- 
tides and nucleosides, and of the evidence that many, 
if not all, of these effects are due to occupancy of 
purinergic receptors. The emerging evidence for 
heterogeneity of purinergic receptors is also examined 
together with the status of stimulus-response coupling 
mechanisms linked to these receptors especially in 
the case of adenosine receptors where this aspect has 
been most thoroughly studied. ‘This article is suffi- 
ciently thorough that in many respects it overshadows 
the subsequent three articles by Maguire and Satchel& 
Su, and Schrader dealing with aspects of purinergic 
receptors in various muscular systems. These latter 
articles provide more detailed information about 
purinergic transmission i these systems but do not 
really add much conceptually. They are therefore 
likely to be of interest o the specialist in this field. 
In some respects the introduction also pre-empts the 
discussion of presynaptic (engagingly misspelt as 
‘presynapric’ intable of contents) purinergic receptors 
by Paton although there is much less overlap in this 
latter case. Purinergic receptors also exist and have 
been examined in systems where no synaptic trans- 
mission is involved. The best characterised of such 
cells is probably the blood platelet for which the 
responses to ADP and adenosine were documented 
in the early 1960’s. This system is examined in a 
very comprehensive article by Haslam and Cusack 
which contains among other things a comprehensive 
list of the ADP and adenosine analogues which have 
been tested in platelets as well as extensive discussion 
on the nature of the receptors and the mechanisms 
by which these purinergic agonists exert their effects. 
Most of the remaining articles have a more clearly 
biochemical f avour. For example, Londos, Wolff and 
Cooper discuss in detail the status of adenosine recep- 
tors in various tissues, the differing actions of adenosine 
and the nature of receptor-cyclase coupling bringing 
out in the process the similarity of this system to that 
used by other hormones, e.g., the catecholamines. It 
is unfortunate, however, that their notation for the 
adenosine receptor sub-types differs from that used 
by other workers. Although the equivalence in the 
different nomenclatures is clearly set out here by 
Londos et al., there is scope for rationalisation, 
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especially since the presence of the intracellular P siderable interest o biochemists and will perhaps 
site further complicates any discussion of adenosine stimulate further work on the extracellular roles of 
receptors. the purine nucleotides and nucleosides. 
Although this book is written with a bias towards 
pharmacology I think many parts of it will be of con- M. C. Scrutton 
Receptor Regulation 
Receptors and Recognition Series B: Volume 13 
Edited by R. J. Lefkowitz 
Chapman and Hall; London, New York, 1981 
viii t 254 pages. $25 -00 
What is meant by receptor egulation? Having read 
this book I must admit being a bit confused! My 
expectation had been to find a series of articles 
describing the phenomena of up-and-down regulation 
together with hopefully some ideas about how these 
changes are brought about and possibly also examina- 
tion of other conditions and mechanisms which lead 
to changes in receptor number or properties. In his 
foreword Dr Lefkowitz describes this area as ‘so vast 
that an encyclopaedic approach is not feasible’ and 
yet by no means all the contributions are recognisable 
within the above context. Possibly my frame of 
reference is too narrow but I can see little relationship 
between the title of the volume and the articles on 
thyroid auto-antibodies and on myasthenia gravis. 
This is not to say that these articles are uninteresting 
in themselves or that receptor-directed antibodies 
are of no significance in the context of receptor 
regulation; but they seem somewhat out of place 
especially if space was at a premium. 
The remaining articles are more closely related 
to the title of the book as I (and, I believe, most 
biochemists) would define it. However even here 
analysis of receptor egulation often forms only a 
minor part of the article. This is particularly the case 
with the review on epidermal growth factor (EGF) 
by Carpenter and Cohen which devotes approximately 
one quarter of the space to receptor internalisation 
and the remainder to description of this agonist and 
of events following occupancy of its receptor. The 
balance is rather better in reviews on regulation of 
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insulin (van Obberghen and Roth) and adrenergic 
receptors (Davies and Lefkowitz) and on the conse- 
quences of denervation for muscle cholinergic recep 
tors (Famborough). All three articles discuss ideas 
and approaches which may well be useful to those 
interested in this area. I was however ather surprised 
to find no mention of the recent work of Levitski and 
his colleagues in the treatment of adrenergic receptor 
regulation. 
It could well be that it is still too early to produce 
a treatment of this area which is satisfying at the 
molecular level. Receptors are still for the most part 
mysterious entities of uncertain size and illdefined 
properties. Morphological regulation by receptor 
internalisation ismore easily examined now that 
high specific activity radioligands are available for 
most receptors but the basis for this phenomenon is
far from being clear at the molecular level. Prospects 
are perhaps better for the adrenergic receptors where 
rapid progress i  being made in purification and where 
a fair insight already exists with respect o the nature 
of receptor coupling to adenylate cyclase. If regula- 
tion is mediated by interplay within the receptor/N 
protein/cyclase complex as initial results uggest a 
better understanding may soon be forthcoming. 
The book is then a volume concerned with the 
properties (including regulation) of some of the 
better characterised receptors and as such is of con- 
siderable interest. Do not however be misled by the 
title which promises more than it delivers. 
M. C. Scrutton 
